Table 2.
Comparison of operative and perioperative outcomes.
| Outcomes | LSOM (n = 160) | Non-LSOM (n = 177) | p-Value |
|---|---|---|---|
| Type of main myoma * | 0.26 | ||
| Intramural (FIGO type 3, 4) | 114 (71.25) | 124 (70.05) | |
| Subserosal (FIGO type 5, 6) | 30 (18.75) | 34 (19.20) | |
| Pedunculated subserosal (FIGO type 7) | 1 (0.62) | 12 (14.12) | |
| Submucosal (FIGO type 0–2) | 6 (3.75) | 4 (2.25) | |
| Intraligamentary (FIGO type 8) | 7 (4.37) | 3 (1.69) | |
| Cervical (FIGO type 8) | 1 (0.62) | 0 | |
| Parasitic (FIGO type 8) | 1 (0.62) | 0 | |
| Maximal myoma diameter (cm, mean ± SD) | 9.20 ± 3.17 | 7.94 ± 2.49 | <0.001 |
| Number of removed myomas (median (range)) | 2 (1–34) | 2 (1–10) | <0.001 |
| Multiple myomas | 135 (84.4%) | 176 (99.4%) | <0.001 |
| Number of myomas >3 cm (median (range)) | 1 (1–10) | 1 (1–6) | <0.001 |
| Weight of the removed myomas (g, mean ± SD) † | 359.52 ± 313.44 | 241.88 ± 202.10 | <0.001 |
| Total operative time, (min, mean ± SD) ‡ | 141.43 ± 72.47 | 147.71 ± 58.06 | 0.38 |
| Concomitant surgery | 6 (3.8%) | 20 (11.4%) | 0.02 |
| Estimated blood loss (mL, mean ± SD) | 411.78 ± 806.64 | 241.16 ± 222.42 | 0.01 |
| Preoperative Hb (g/dL) | 12.64 ± 1.36 | 12.34 ± 1.40 | 0.04 |
| Postoperative Hb (g/dL) | 9.48 ± 1.66 | 9.56 ± 1.63 | 0.66 |
| Difference in Hb (g/dL) | 3.16 ± 1.69 | 2.78 ± 1.58 | 0.03 |
| Transfusion | 27 (25.8%) | 35 (35.1%) | 0.59 |
| Number of transfused packs (median (range)) | 0 (0–17) | 0 (0–5) | 0.42 |
| Length of hospital stay (days, mean ± SD) | 2 (2–22) | 3 (0–8) | <0.001 |
| Postoperative fever (within 48 h) | 21 (13.1%) | 12 (6.8%) | 0.08 |
Data are n ± SD, n (range), or n (%) unless otherwise stated. * FIGO, leiomyoma subclassification system [22]. † Data were available from 120 cases of LSOM and 136 cases of non-LSOM. ‡ Time from skin incision to skin closure. LSOM, locking suture on myoma: SD, standard deviation: Hb, hemoglobin: FIGO, the International Federation of Gynecology and Obstetrics.